No Data
No Data
Press Release: Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
Express News | Twist Bioscience Corp - Agreement Excludes Synbio, Ngs, and Data Storage Revenue
Express News | Twist Bioscience Corp - Retains Full Rights to Future Biopharma Collaborations
Express News | Twist Bioscience Corp - to Retain All Upfront, Service and Other Revenue
XOMA Royalty Significantly Expands Its Royalty and Milestone Portfolio With the Addition of Over 60 Early-Stage Programs From Twist Bioscience
Express News | Twist Bioscience Enters Into Royalty Purchase Agreement With XOMA Royalty for $15 Million in Cash